phase readout
saveNCT07158242: A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
RECRUITINGupdated 17m ago
community read0 votes
Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Moderately to Severely Active Ulcerative Colitis
view source ↗
comments(0)
5-min edit window · permanent after that